ES544316A0 - Un metodo para preparar un peptido - Google Patents

Un metodo para preparar un peptido

Info

Publication number
ES544316A0
ES544316A0 ES544316A ES544316A ES544316A0 ES 544316 A0 ES544316 A0 ES 544316A0 ES 544316 A ES544316 A ES 544316A ES 544316 A ES544316 A ES 544316A ES 544316 A0 ES544316 A0 ES 544316A0
Authority
ES
Spain
Prior art keywords
peptide
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544316A
Other languages
English (en)
Other versions
ES8702438A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Original Assignee
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University filed Critical Tulane University
Publication of ES544316A0 publication Critical patent/ES544316A0/es
Publication of ES8702438A1 publication Critical patent/ES8702438A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES544316A 1984-06-18 1985-06-18 Un metodo para preparar un peptido Expired ES8702438A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,673 US4632979A (en) 1984-06-18 1984-06-18 Therapeutic LHRH analogs

Publications (2)

Publication Number Publication Date
ES544316A0 true ES544316A0 (es) 1987-01-01
ES8702438A1 ES8702438A1 (es) 1987-01-01

Family

ID=24491153

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544316A Expired ES8702438A1 (es) 1984-06-18 1985-06-18 Un metodo para preparar un peptido

Country Status (12)

Country Link
US (1) US4632979A (es)
EP (1) EP0171477A3 (es)
JP (1) JPS617297A (es)
AU (1) AU4376485A (es)
CA (1) CA1257950A (es)
DK (1) DK615084A (es)
ES (1) ES8702438A1 (es)
FI (1) FI850193L (es)
NO (1) NO852439L (es)
NZ (1) NZ212454A (es)
PT (1) PT80658B (es)
ZA (1) ZA854590B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
NZ213759A (en) * 1984-10-19 1989-01-27 Genentech Inc Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
EP0328090A3 (en) * 1988-02-10 1990-08-16 Abbott Laboratories Lhrh analogs
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
JP2672677B2 (ja) * 1989-02-09 1997-11-05 タツプ・フアーマシユーテイカルズ・インコーポレイテツド Lhrh同族体
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
HU208158B (en) * 1990-02-20 1993-08-30 Syntex Inc Process for the synthesis of 1h-rh analogs by temporary protection
JPH06510046A (ja) * 1991-08-26 1994-11-10 アボツト・ラボラトリーズ 治療薬の舌下または頬投与のための組成物及び方法
CN102112145B (zh) 2008-06-12 2014-07-30 辛它可辛有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50142563A (es) * 1974-04-26 1975-11-17
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
US4071622A (en) * 1976-02-11 1978-01-31 Abbott Laboratories Treatment of a mammary or DMBA inducible tumor
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4244946A (en) * 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US4253997A (en) * 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
US4321260A (en) * 1980-05-22 1982-03-23 Ayerst, Mckenna & Harrison Inc. Method of using gonadorelin for the treatment of benign prostatic hyperplasia
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists

Also Published As

Publication number Publication date
PT80658A (en) 1985-07-01
US4632979A (en) 1986-12-30
EP0171477A2 (en) 1986-02-19
JPS617297A (ja) 1986-01-13
DK615084A (da) 1985-12-19
EP0171477A3 (en) 1987-10-14
CA1257950A (en) 1989-07-25
PT80658B (en) 1986-12-09
ES8702438A1 (es) 1987-01-01
FI850193A0 (fi) 1985-01-16
AU4376485A (en) 1986-01-02
NZ212454A (en) 1988-09-29
NO852439L (no) 1985-12-19
FI850193L (fi) 1985-12-19
DK615084D0 (da) 1984-12-20
ZA854590B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
ES547326A0 (es) Un metodo para preparar esterol-liposomas
ES542310A0 (es) Procedimiento para preparar un polipeptido
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES543257A0 (es) Procedimiento para preparar un polipeptido
ES548307A0 (es) Un procedimiento para preparar polipeptidos
ES548388A0 (es) Un procedimiento para la preparacion de un peptido.
ES551519A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES520997A0 (es) Un metodo para producir un peptido.
ES557321A0 (es) Procedimiento para producir un material fotomodulador
ES557006A0 (es) Un metodo para preparar 6-hidroxi-2-acetilnaftaleno
ES556503A0 (es) Un metodo para sintetizar compuestos de ascorbato-2-polifosfato
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES545386A0 (es) Un procedimiento para preparar un organotitanato
ES544316A0 (es) Un metodo para preparar un peptido
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES555649A0 (es) Un metodo para eliminar la metionina n-terminal de una metionil-proteina
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES550002A0 (es) Un procedimiento para preparar un poliuretano
ES549180A0 (es) Un metodo para preparar nuevos derivados de cefem
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES544862A0 (es) Un metodo para preparar un compuesto de morfolinol
ES501878A0 (es) Un procedimiento para preparar un peptido
ES542212A0 (es) Un procedimiento para la preparacion de un peptido

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603